The five-day Bio-Europe Spring 2020 conference, possibly the first ever life sciences partnering event staged in an all-virtual format, ended on Friday, March 27, with high hopes that the industry would return to face-to-face interactions next year in Barcelona.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anpac Bio, Astrotech, CDISC, Cohealo, Core Mobile, Cynergistek, Dawex, Deltatrak, Forward Science, Nanovibronix, Nexstim, Phunware, Pieces Technologies, Seek Thermal, Smiledirectclub, Well Health Technologies.
Biopharma industry leaders in China who were the first to experience the chaos of the COVID-19 pandemic shared their thoughts during a closing plenary session of the virtual Bio-Europe Spring 2020 meeting.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avexis, BMS, Cstone, Cytodyn, Eisai, Genentech, Humanigen, Intelgenx, Lupin, Mylan, Novartis, Pharming, Rockwell, Sanofi, Translate Bio.
The U.S. FDA has OK’d expanded labeling for Physiq Inc.’s continuous remote monitoring system, Pinpointiq, for use during the COVID-19 pandemic. The machine learning-based platform, including Multivariate Change Index (MCI), will allow clinicians to track physiologic changes in homebound, quarantined or high-risk patients with confirmed or suspected COVID-19 – freeing up hospital beds for the most severe cases and reducing exposure of doctors and nurses to the highly contagious disease.
Leuven, Belgium-based Midiagnostics NV, which is looking to bring miniaturized, rapid, blood-based tests with built-in connectivity to both patients and clinicians, reported the completion of a €14 million (US$15.4 million) investment round. The company intends to use the funds to speed the development of its nanofluidic processor on a chip and prepare it for industrial-scale manufacturing.